ER IHC Testing in Accordance with Guidelines Established the American Society of Clinical Oncology (ASCO) and by the College of American Pathologists (CAP)

被引：0
|
作者：
Phillips, T. [1 ]
Strickland, A. [1 ]
Webster, S. [1 ]
Welcher, R. [1 ]
机构：
[1] Dako N Amer Inc, Carpinteria, CA USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
234
引用
收藏
页码：58A / 58A
页数：1
相关论文
共 50 条
  • [21] Breast Cancers with Discordant HER2 Fluorescence In Situ Hybridization (FISH) Positive (Group1) and Immunohistochemistry (IHC) Negative (0/1+) Results Following 2018 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) Guidelines
    Wilcock, Diane
    Jedrzkiewicz, Jolanta
    Beech, Cameron
    Gulbahce, H. Evin
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [22] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
    Bartley, Angela N.
    Washington, Mary Kay
    Ventura, Christina B.
    Ismaila, Nofisat
    Colasacco, Carol
    Benson, Al B., III
    Carrato, Alfredo
    Gulley, Margaret L.
    Jain, Dhanpat
    Kakar, Sanjay
    Mackay, Helen J.
    Streutker, Catherine
    Tang, Laura
    Troxell, Megan
    Ajani, Jaffer A.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (12) : 1345 - 1363
  • [23] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
    Bartley, Angela N.
    Washington, Mary Kay
    Colasacco, Carol
    Ventura, Christina B.
    Ismaila, Nofisat
    Benson, Al B., III
    Carrato, Alfredo
    Gulley, Margaret L.
    Jain, Dhanpat
    Kakar, Sanjay
    Mackay, Helen J.
    Streutker, Catherine
    Tang, Laura
    Troxell, Megan
    Ajani, Jaffer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04) : 446 - +
  • [24] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
    Bartley, Angela N.
    Washington, Mary Kay
    Ventura, Christina B.
    Ismaila, Nofisat
    Colasacco, Carol
    Benson, Al B., III
    Carrato, Alfredo
    Gulley, Margaret L.
    Jain, Dhanpat
    Kakar, Sanjay
    Mackay, Helen J.
    Streutker, Catherine
    Tang, Laura
    Troxell, Megan
    Ajani, Jaffer A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (06) : 647 - 669
  • [25] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Wolff, Antonio C.
    Mangu, Pamela B.
    Temin, Sarah
    JOURNAL OF ONCOLOGY PRACTICE, 2010, 6 (04) : 195 - 197
  • [26] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Dowsett, Mitch
    Allred, D. Craig
    Hagerty, Karen L.
    Badve, Sunil
    Fitzgibbons, Patrick L.
    Francis, Glenn
    Goldstein, Neil S.
    Hayes, Malcolm
    Hicks, David G.
    Lester, Susan
    Love, Richard
    Mangu, Pamela B.
    McShane, Lisa
    Miller, Keith
    Osborne, C. Kent
    Paik, Soonmyung
    Perlmutter, Jane
    Rhodes, Anthony
    Sasano, Hironobu
    Schwartz, Jared N.
    Sweep, Fred C. G.
    Taube, Sheila
    Torlakovic, Emina Emilia
    Valenstein, Paul
    Viale, Giuseppe
    Visscher, Daniel
    Wheeler, Thomas
    Williams, R. Bruce
    Wittliff, James L.
    Wolff, Antonio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2784 - 2795
  • [27] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Dowsett, Mitch
    Allred, D. Craig
    Hagerty, Karen L.
    Badve, Sunil
    Fitzgibbons, Patrick L.
    Francis, Glenn
    Goldstein, Neil S.
    Hayes, Malcolm
    Hicks, David G.
    Lester, Susan
    Love, Richard
    Mangu, Pamela B.
    McShane, Lisa
    Miller, Keith
    Osborne, C. Kent
    Paik, Soonmyung
    Perlmutter, Jane
    Rhodes, Anthony
    Sasano, Hironobu
    Schwartz, Jared N.
    Sweep, Fred C. G.
    Taube, Sheila
    Torlakovic, Emina Emilia
    Valenstein, Paul
    Viale, Giuseppe
    Visscher, Daniel
    Wheeler, Thomas
    Williams, R. Bruce
    Wittliff, James L.
    Wolff, Antonio C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (06) : 907 - 922
  • [28] Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 testing in breast cancer
    Shah, Sejal S.
    Ketterling, Rhett P.
    Perez, Edith A.
    Chen, Beiyun
    VIRCHOWS ARCHIV, 2008, 452 : S23 - S24
  • [29] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
    Bartley, Angela N.
    Washington, Mary Kay
    Ismaila, Nofisat
    Ajani, Jaffer A.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (01) : 53 - +
  • [30] Reappraisal of Human Epidermal Growth Factor Receptor 2 (HER2) in High-grade Urothelial Carcinoma (HGUCa) Based on American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Clinical Practice Guidelines, 2018
    Mohanty, Sambit
    Tiwari, Ankit
    Baisakh, Manas
    Naik, Subhasini
    Chawla, Preeti
    Das, Subodh
    Pradhan, Manas
    Satapathy, Kali
    Dhillon, Jasreman
    MODERN PATHOLOGY, 2019, 32
12345